By functionally interrogating cancer-associated fibroblasts heterogeneity using the same therapeutics received by patients, the authors identified three functional subtypes: robustly protective of cancers and highly expressing HGF and FGF7; moderately protective of cancers and highly expressing FGF7; and those providing minimal protection.
[Cancer Cell]
7992332
{7992332:CCCCCCCC}
apa
50
1
167569
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
